A high adalimumab induction dosing regimen achieves clinical and endoscopic remission in super-refractory ulcerative colitis / Una pauta de inducción con dosis altas de adalimumab consigue la remisión clínica y endoscópica en colitis ulcerosa superrefractaria
Gastroenterol. hepatol. (Ed. impr.)
; 45(10): 780-781, dic. 2022.
Article
in English
| IBECS
| ID: ibc-211878
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
Search on Google
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Patient Discharge
/
Physical Examination
/
Referral and Consultation
/
Colitis, Ulcerative
/
Adalimumab
/
Inpatients
Limits:
Adult
/
Female
/
Humans
Language:
English
Journal:
Gastroenterol. hepatol. (Ed. impr.)
Year:
2022
Document type:
Article
Institution/Affiliation country:
Hospital Universitari de Bellvitge/Spain